Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Orthofix Medical Inc. regarding a class action lawsuit due to allegations of misleading statements and inappropriate conduct by the company's management team [1][2]. Group 1: Allegations and Class Action Details - The class period for the lawsuit is from October 11, 2022, to September 12, 2023 [1]. - Allegations include that Orthofix's management engaged in "repeated inappropriate and offensive conduct" that violated the company's code of conduct and was inconsistent with its stated values [1]. - The lawsuit claims that the management's conduct followed prior assurances of ethical business practices and a strong performance-based culture [1]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares during the specified class period are encouraged to register for the class action by October 21, 2024 [2]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. - There is no cost or obligation for shareholders to participate in the case [2]. Group 3: About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates inclusive (the "Class Period"), of the important October 21, 2024 lead plaintiff deadline. SO WHAT: If you purchased Orthofix common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ...

NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/orthofix-loss-submission-form/?id=103168&from=3 CLASS PERIOD: October 11, 2 ...

SAN DIEGO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Orthofix Medical Inc. (NASDAQ: OFIX) stock between October 11, 2022 and September 12, 2023. Orthofix is a global spine and orthopedics company that offers biologics, spinal hardware, bone growth therapies, and specialized orthopedic solutions, among other things, to healthcare professionals throughout the world. For mor ...

NEW YORK, Sept. 16, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/orthofix-loss-submission-form/?id=102394&from=4 CLASS PERIOD: October 11, 2022 ...

NEW YORK, Sept. 12, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/orthofix-loss-submission-form/?id=101861&from=4 CLASS PERIOD: October 11, 2022 ...

NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ: OFIX) and certain current and former officers and directors of Orthofix and SeaSpine Holdings Corporation ("SeaSpine"). Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities ...

NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Orthofix Medical Inc. ("Orthofix " or the "Company") (NASDAQ: OFIX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Orthofix investors who were adversely affected by alleged securities fraud between October 11, 2022 and September 12, 2023. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/orthofix-lawsu ...

NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/orthofix-loss-submission-form/?id=101222&from=3 CLASS PERIOD: October 11, 2 ...

Core Points - A class action lawsuit has been filed against Orthofix Medical, Inc. for failing to disclose inappropriate conduct by certain management team members during the class period from October 11, 2022, to September 12, 2023 [1][3] - Following the announcement of the termination of three management team members due to inappropriate conduct, Orthofix's share price dropped by approximately 30%, from $18.63 to $13.01 per share [2] Company Actions - On September 12, 2023, Orthofix's Board of Directors unanimously decided to terminate and replace three members of the management team after an investigation revealed repeated inappropriate conduct [2] - The class action alleges that the company failed to disclose this misconduct, which significantly impacted investor confidence and share price [3] Legal Information - Investors have until October 21, 2024, to apply to be appointed as lead plaintiff in the class action lawsuit [1] - The law firm Kirby McInerney LLP is representing the investors and has a history of successful recoveries in securities litigation [5]